Peter Maag sold $229k of CDNA
director at CareDx, Inc.. 13,281 shares at an average of $17.23, traded Apr 30, 2025, filed May 2, 2025.
Score components
- +15RoleDirector
- +13Trade size$229k at market
- 0Share of holdings soldSold 4.0% of holdings
- +15Cluster3 insiders selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000950170-25-062877, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Apr 30, 2025 | SOpen-market sale Common Stock10b5-1 | -13,281 | $17.23 | $229k | 316,743 | May 2, 2025 |
Related signals
Other insiders at CareDx, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 12Weak | CareDx, Inc. | Jeffrey Adam Novack Secretary and General Counsel | $91k 4,441 shares | -3% | |
| 29Weak | CareDx, Inc. | John Walter Hanna JR President and CEO | $412k 19,480 shares | -3% | |
| 17Weak | CareDx, Inc. | John Walter Hanna JR President and CEO | $214k 10,156 shares | -2% | |
| 6Weak | CareDx, Inc. | Jeffrey Adam Novack Secretary and General Counsel | $140k 7,293 shares | -7% | |
| 1Weak | CareDx, Inc. | Jeffrey Adam Novack Secretary and General Counsel | $42k 2,688 shares | -2% | |
| 1Weak | CareDx, Inc. | Jeffrey Adam Novack Secretary and General Counsel | $34k 2,688 shares | -2% | |
| 7Weak | CareDx, Inc. | Peter Maag director | $186k 10,000 shares | -3% | |
| 27Weak | CareDx, Inc. | Hannah Valantine director | $203k 10,570 shares | -21% | |
| 22Weak | CareDx, Inc. | Peter Maag director | $192k 10,000 shares | -3% | |
| 41Moderate | CareDx, Inc. | William A Hagstrom director | $386k 19,391 shares | -26% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.